Bristol-Myers Squibb Co
XHAM:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
T
|
Terracom Ltd
F:2GF
|
AU |
|
A
|
AeroVironment Inc
SWB:JPX
|
US |
|
C
|
Commonwealth Bank of Australia
SWB:CWW
|
AU |
|
B
|
Byd Electronic (International) Co Ltd
XMUN:4BY
|
CN |
|
K
|
Korea Computer Inc
KOSDAQ:054040
|
KR |
|
Civista Bancshares Inc
F:44Q
|
US |
|
Cadoux Ltd
ASX:CCM
|
AU |
|
Pigeon Corp
F:9N3
|
JP |
|
Faze Three Ltd
BSE:530079
|
IN |
|
PlasCred Circular Innovations Inc
F:XV2
|
CA |
|
Wolverine World Wide Inc
NYSE:WWW
|
US |
|
L
|
Landore Resources Ltd
XMUN:LMK1
|
GG |
|
China Yangtze Power Co Ltd
F:CYZB
|
CN |
|
R
|
Radcom Ltd
SWB:RAM
|
IL |
|
Solstice Advanced Materials Inc
NASDAQ:SOLS
|
US |
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
|
W
|
WPP PLC
F:0WPA
|
UK |
|
Midea Group Co Ltd
OTC:MGCOF
|
CN |
|
B
|
Bajaj Auto Ltd
BSE:532977
|
IN |
|
Meridian Energy Ltd
F:15M1
|
NZ |
|
1
|
1CM Inc
CNSX:EPIC
|
CA |
|
A
|
Atlas Technologies Corp
TSE:9563
|
JP |
Bankruptcy Probability
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bristol-Myers Squibb Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
503.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
370B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
201.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bristol-Myers Squibb Co has total debt of 42.4B USD. This includes both short-term (259m USD) and long-term (42.1B USD) debt.
You can find a full breakdown on its Balance Sheet.